title: How to Manage (Treat) Immediate-type Adverse Reactions to GBCA.
abstract: Acute nonrenal adverse reactions to gadolinium-based contrast agents are infrequent and occur often unexpectedly. Most reactions are self-limiting and do not require treatment. The remaining adverse reactions are either moderate or severe and they require medical treatment. Prompt and effective treatment is very important and requires knowledge, training, and preparation.
authors.affiliation: Department of Diagnostic Radiology, Copenhagen University Hospital Herlev-Gentofte, Herlev, Denmark.
authors.forename: Henrik S
authors.initials: HS
authors.lastname: Thomsen
mesh_terms: D002614:Chelating Agents / Q000009:adverse effects; D003287:Contrast Media / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D019317:Evidence-Based Medicine; D005682:Gadolinium / Q000009:adverse effects*; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000139:chemically induced / Q000175:diagnosis* / Q000628:therapy*; D008279:Magnetic Resonance Imaging / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D002614:Chelating Agents; D003287:Contrast Media; D005682:Gadolinium